Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

BACKGROUND: Paroxysmal nocturnal hemoglobinuria (PNH) is associated with an increased risk of thrombosis through unknown mechanisms. DESIGN AND METHODS: We studied 23 patients with PNH, before and after five and 11 weeks of treatment with eculizumab. We examined markers of thrombin generation and re...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Helley, Dominique, de Latour, Régis Peffault, Porcher, Raphaël, Rodrigues, Celso Arrais, Galy-Fauroux, Isabelle, Matheron, Jeanne, Duval, Arnaud, Schved, Jean-François, Fischer, Anne-Marie, Socié, Gérard
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2010
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2857186/
https://ncbi.nlm.nih.gov/pubmed/20081060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.016121
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares